Piramal Pharma's Stock Reaches All-Time High, Outperforms Sector and Sensex
Piramal Pharma, a leading pharmaceutical company, has reached an all-time high stock price of Rs. 284.35 on November 3rd, 2024. The company's stock has outperformed the sector by 4.56% and has been on a consecutive gain for the past 4 days, with a 9.82% increase in returns. Piramal Pharma's strong portfolio and commitment to innovation have contributed to its remarkable 1-year performance of 169.97%.
Piramal Pharma, a leading pharmaceutical company in the largecap industry, has reached an all-time high stock price of Rs. 284.35 on November 3rd, 2024. This significant increase in stock price has been attributed to the company's strong performance in the market.
According to MarketsMOJO, a leading stock market analysis platform, Piramal Pharma's stock is currently rated as 'Hold'. The company's stock has outperformed the sector by 4.56% and has been on a consecutive gain for the past 4 days, with a 9.82% increase in returns during this period.
The stock also saw a high volatility today, with an intraday volatility of 6.2%, calculated from the weighted average price. However, Piramal Pharma's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In comparison to the Sensex performance of 25.37%, Piramal Pharma has shown a remarkable 1-year performance of 169.97%. This further solidifies the company's position as a top performer in the pharmaceutical industry.
Piramal Pharma's success can be attributed to its strong portfolio of products and its commitment to innovation and quality. With its consistent growth and positive market performance, Piramal Pharma is a company to watch out for in the largecap industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
